IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
IQVIA HOLDINGS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$265.88−1.02 (-0.38%)
Close on Oct 19, 2026
- Market cap
- $44.48B
- P/E (TTM)
- 33.0
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
95.3%
157M of 165M shares
Institutional holders
1,087
135 new, 108 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 17 sales
Net sold $51.36M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 15,166,087 | 8.30% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 12,714,783 | 7.49% | 13G (passive) | Mar 31, 2026 |
| Harris Associates L P | 11,753,182 | 6.80% | 13G (passive) amendment | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IQV | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14,549,693 | 8.84% | $2.81B | −477,751 | 0.04% |
| Harris Associates L P | 12,183,830 | 7.40% | $2.35B | +555 | 3.12% |
| Vanguard Capital Management LLC | 10,905,053 | 6.63% | $2.11B | −121,930 | 0.05% |
| State Street Corp | 7,508,244 | 4.56% | $1.45B | +31,282 | 0.04% |
| Vanguard Portfolio Management LLC | 7,501,993 | 4.56% | $1.45B | −74,008 | 0.07% |
| JPMorgan Chase & Co | 6,139,775 | 3.73% | $1.19B | +732,085 | 0.07% |
| Artisan Partners Limited Partnership | 4,743,434 | 2.88% | $916.53M | −315,431 | 1.45% |
| Boston Partners | 4,466,016 | 2.71% | $865.50M | +227,058 | 0.77% |
| Geode Capital Management, LLC | 4,454,134 | 2.71% | $857.16M | −8,918 | 0.05% |
| Invesco Ltd. | 3,275,141 | 1.99% | $632.82M | +13,363 | 0.05% |
| Morgan Stanley | 2,707,252 | 1.64% | $523.10M | +97,385 | 0.03% |
| Norges Bank | 2,264,944 | 1.38% | $437.63M | New | 0.04% |
| Franklin Resources Inc | 2,105,185 | 1.28% | $406.76M | +1,600,943 | 0.09% |
| Goldman Sachs Group Inc | 1,949,797 | 1.18% | $376.74M | +772,517 | 0.03% |
| Dimensional Fund Advisors LP | 1,735,452 | 1.05% | $335.33M | +77,756 | 0.06% |
| Northern Trust Corp | 1,709,161 | 1.04% | $330.24M | −20,835 | 0.04% |
| Alliancebernstein L.P. | 1,643,102 | 1.00% | $280.21M | −1,235,795 | 0.09% |
| UBS Asset Management Americas Inc | 1,634,264 | 0.99% | $315.77M | +134,997 | 0.06% |
| Aqr Capital Management LLC | 1,536,874 | 0.93% | $296.95M | +296,016 | 0.10% |
| Longview Partners (Guernsey) LTD | 1,500,760 | 0.91% | $289.98M | −396,714 | 4.71% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,087 | 157M | 95.3% | 135 / 399 | 429 / 108 | 17M | 17M |
| Q1 2026 | 1,071 | 157M | 95.3% | 121 / 412 | 407 / 182 | 36M | 20M |
| Q4 2025 | 1,145 | 161M | 98.0% | 231 / 409 | 365 / 72 | 18M | 17M |
| Q3 2025 | 1,007 | 162M | 98.3% | 143 / 401 | 344 / 106 | 18M | 18M |
| Q2 2025 | 980 | 163M | 98.8% | 125 / 426 | 324 / 127 | 22M | 14M |
| Q1 2025 | 991 | 154M | 93.9% | 109 / 369 | 378 / 103 | 12M | 11M |
| Q4 2024 | 1,003 | 154M | 93.7% | 130 / 328 | 429 / 173 | 16M | 19M |
| Q3 2024 | 1,063 | 159M | 96.7% | 112 / 445 | 357 / 60 | 25M | 9M |
| Q2 2024 | 1,021 | 159M | 96.8% | 101 / 434 | 328 / 85 | 11M | 21M |
| Q1 2024 | 1,014 | 170M | 100.0% | 118 / 384 | 363 / 52 | 12M | 11M |
| Q4 2023 | 958 | 169M | 100.0% | 130 / 280 | 420 / 101 | 17M | 12M |
| Q3 2023 | 943 | 164M | 99.4% | 98 / 358 | 349 / 71 | 13M | 12M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of IQV | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 5,299,333 | 3.22% | $1.02B | 0.04% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 4,323,399 | 2.63% | $835.37M | 0.05% | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 3,616,429 | 2.20% | $698.77M | 0.31% | Jun 30, 2026 |
| Oakmark Select Fund | 2,605,500 | 1.58% | $503.43M | 6.05% | Jun 30, 2026 |
| Oakmark Fund | 2,565,300 | 1.56% | $495.67M | 2.06% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 2,295,747 | 1.39% | $443.58M | 0.05% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 2,170,374 | 1.32% | $395.46M | 0.05% | May 31, 2026 |
| Vanguard Windsor Ii Fund | 1,764,400 | 1.07% | $414.67M | 0.62% | Jul 31, 2026 |
| Vanguard Value Index Fund | 1,587,774 | 0.96% | $306.79M | 0.12% | Jun 30, 2026 |
| JPMorgan Mid Cap Value Fund | 1,337,076 | 0.81% | $258.35M | 2.31% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 1,179,065 | 0.72% | $227.82M | 0.56% | Jun 30, 2026 |
| Vanguard Mid-Cap Value Index Fund | 1,071,971 | 0.65% | $207.13M | 0.56% | Jun 30, 2026 |
| Disciplined Value Fund | 1,055,968 | 0.64% | $204.03M | 1.04% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 1,023,708 | 0.62% | $240.59M | 0.25% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 906,035 | 0.55% | $175.06M | 0.05% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ari Bousbib | See Remarks, Director | 1,526,400 | 0.93% | Jul 31, 2026 |
| James G. Berkshire | See Remarks | 13,558 | 0.01% | Sep 4, 2026 |
| W. Richard Staub | See Remarks | 13,312 | 0.01% | Aug 4, 2026 |
| Bhavik Patel | See Remarks | 1,348 | 0.00% | Aug 4, 2026 |
| Keriann Cherofsky | See Remarks | 2,989 | 0.00% | Jul 31, 2026 |
| Eric Sherbet | See Remarks | 20,999 | 0.01% | Jul 31, 2026 |
| Michael J. Fedock | See Remarks | 9,472 | 0.01% | Feb 17, 2026 |
| Bernd Haas | See Remarks | 24,394 | 0.01% | Feb 17, 2026 |
| Alistair Grenfell | See Remarks | 29,669 | 0.02% | Feb 11, 2026 |
| Ronald E. Bruehlman | See Remarks | 55,996 | 0.03% | Feb 10, 2026 |
| Jim Fasano | Director | 1,063 | 0.00% | Jul 16, 2026 |
| John G. Danhakl | Director | 34,857 | 0.02% | Jul 16, 2026 |
| Morris Leslie Wims | Director | 2,058 | 0.00% | Jul 16, 2026 |
| Colleen A. Goggins | Director | 14,453 | 0.01% | Jul 16, 2026 |
| John M. Leonard | Director | 16,946 | 0.01% | Apr 27, 2026 |
| William G. Kaelin Jr | Director | – | – | Apr 27, 2026 |
| Carol Burt | Director | 7,533 | 0.00% | Apr 27, 2026 |
| Sheila A. Stamps | Director | 2,058 | 0.00% | Apr 27, 2026 |
| John Connaughton | Director | 1,047 | 0.00% | Feb 7, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| James G. Berkshire See Remarks | Sep 2, 2026 | Option exercise | +5,381 | $131.82 | $709.32K | 13,558 |
| James G. Berkshire See Remarks | Sep 2, 2026 | Sale | −2,668 | $261.33 | $697.23K | 10,890 |
| James G. Berkshire See Remarks | Sep 2, 2026 | Returned to company | −2,713 | $261.54 | $709.56K | 8,177 |
| W. Richard Staub See Remarks | Aug 3, 2026 | Sale | −5,500 | $232.68 | $1.28M | 13,312 |
| Bhavik Patel See Remarks | Jul 31, 2026 | Sale | −1,855 | $235.27 | $436.43K | 1,348 |
| Eric Sherbet See Remarks | Jul 29, 2026 | Sale | −5,000 | $249.16 | $1.25M | 20,999 |
| Keriann Cherofsky See Remarks | Jul 29, 2026 | Sale | −558 | $245.21 | $136.83K | 2,989 |
| Ari Bousbib See Remarks, Director | Jul 29, 2026 | Sale | −4,584 | $246.85 | $1.13M | 983,098 |
| Ari Bousbib See Remarks, Director | Jul 29, 2026 | Option exercise | +156,206 | $78.21 | $12.22M | 992,147 |
| Ari Bousbib See Remarks, Director | Jul 29, 2026 | Sale | −4,465 | $247.10 | $1.10M | 987,682 |
| Ari Bousbib See Remarks, Director | Jul 29, 2026 | Returned to company | −47,858 | $244.60 | $11.71M | 838,010 |
| Ari Bousbib See Remarks, Director | Jul 29, 2026 | Sale | −53,191 | $244.78 | $13.02M | 885,868 |
| Ari Bousbib See Remarks, Director | Jul 29, 2026 | Sale | −44,039 | $246.08 | $10.84M | 939,059 |
| Ari Bousbib See Remarks, Director | Jul 29, 2026 | Returned to company | −2,069 | $247.00 | $511.04K | 835,941 |
| John G. Danhakl Director | Apr 23, 2026 | Award | +1,571 | – | – | 30,612 |
| Carol Burt Director | Apr 23, 2026 | Award | +1,571 | – | – | 7,533 |
| John M. Leonard Director | Apr 23, 2026 | Award | +1,571 | – | – | 16,946 |
| Colleen A. Goggins Director | Apr 23, 2026 | Award | +1,571 | – | – | 14,453 |
| Bernd Haas See Remarks | Feb 13, 2026 | Tax withholding | −20 | $166.94 | $3.34K | 24,394 |
| Michael J. Fedock See Remarks | Feb 13, 2026 | Tax withholding | −123 | $166.94 | $20.53K | 9,472 |
| Ari Bousbib See Remarks, Director | Feb 8, 2026 | Award | +57,177 | – | – | 864,340 |
| Ari Bousbib See Remarks, Director | Feb 8, 2026 | Tax withholding | −28,399 | $187.49 | $5.32M | 835,941 |
| Ronald E. Bruehlman See Remarks | Feb 8, 2026 | Tax withholding | −6,801 | $187.49 | $1.28M | 44,103 |
| Ronald E. Bruehlman See Remarks | Feb 8, 2026 | Award | +16,335 | – | – | 50,904 |
| Alistair Grenfell See Remarks | Feb 8, 2026 | Award | +11,795 | – | – | 29,669 |
| Alistair Grenfell See Remarks | Feb 8, 2026 | Tax withholding | −5,545 | $187.49 | $1.04M | 24,124 |
| Keriann Cherofsky See Remarks | Feb 8, 2026 | Tax withholding | −415 | $187.49 | $77.81K | 3,547 |
| Keriann Cherofsky See Remarks | Feb 8, 2026 | Award | +1,087 | – | – | 3,962 |
| Michael J. Fedock See Remarks | Feb 8, 2026 | Award | +6,735 | – | – | 12,015 |
| Michael J. Fedock See Remarks | Feb 8, 2026 | Tax withholding | −2,420 | $187.49 | $453.73K | 9,595 |
| Bernd Haas See Remarks | Feb 8, 2026 | Award | +8,265 | – | – | 24,854 |
| Bernd Haas See Remarks | Feb 8, 2026 | Tax withholding | −440 | $187.49 | $82.50K | 24,414 |
| Eric Sherbet See Remarks | Feb 8, 2026 | Award | +6,806 | – | – | 27,914 |
| Eric Sherbet See Remarks | Feb 8, 2026 | Tax withholding | −1,915 | $187.49 | $359.04K | 25,999 |
| W. Richard Staub See Remarks | Feb 8, 2026 | Award | +2,722 | – | – | 19,618 |
| W. Richard Staub See Remarks | Feb 8, 2026 | Tax withholding | −806 | $187.49 | $151.12K | 18,812 |
| James G. Berkshire See Remarks | Feb 8, 2026 | Tax withholding | −1,280 | $187.49 | $239.99K | 8,177 |
| James G. Berkshire See Remarks | Feb 8, 2026 | Award | +2,722 | – | – | 9,457 |
| Bhavik Patel See Remarks | Feb 8, 2026 | Award | +4,083 | – | – | 5,123 |
| Bhavik Patel See Remarks | Feb 8, 2026 | Tax withholding | −1,920 | $187.49 | $359.98K | 3,203 |
| Michael J. Fedock See Remarks | Feb 7, 2026 | Tax withholding | −111 | $187.49 | $20.81K | 5,280 |
| Michael J. Fedock See Remarks | Jan 28, 2026 | Tax withholding | −381 | $239.76 | $91.35K | 5,391 |
| Ari Bousbib See Remarks, Director | Dec 18, 2025 | Returned to company | −13,436 | $222.91 | $3.00M | 807,163 |
| Ari Bousbib See Remarks, Director | Dec 18, 2025 | Sale | −36,564 | $222.43 | $8.13M | 820,599 |
| Ari Bousbib See Remarks, Director | Dec 18, 2025 | Option exercise | +50,000 | $59.90 | $3.00M | 857,163 |
| Eric Sherbet See Remarks | Oct 29, 2025 | Option exercise | +10,000 | $131.82 | $1.32M | 31,108 |
| Eric Sherbet See Remarks | Oct 29, 2025 | Sale | −4,000 | $219.70 | $878.80K | 27,108 |
| Eric Sherbet See Remarks | Oct 29, 2025 | Returned to company | −6,000 | $219.72 | $1.32M | 21,108 |
| Ari Bousbib See Remarks, Director | Oct 29, 2025 | Sale | −7,315 | $218.32 | $1.60M | 876,640 |
| Ari Bousbib See Remarks, Director | Oct 29, 2025 | Sale | −800 | $217.58 | $174.06K | 883,955 |
| Ari Bousbib See Remarks, Director | Oct 29, 2025 | Option exercise | +77,592 | $59.90 | $4.65M | 884,755 |
| Ari Bousbib See Remarks, Director | Oct 29, 2025 | Sale | −13,741 | $219.29 | $3.01M | 862,899 |
| Ari Bousbib See Remarks, Director | Oct 29, 2025 | Sale | −4,600 | $220.11 | $1.01M | 858,299 |
| Ari Bousbib See Remarks, Director | Oct 29, 2025 | Sale | −26,128 | $221.31 | $5.78M | 832,171 |
| Ari Bousbib See Remarks, Director | Oct 29, 2025 | Sale | −3,973 | $221.97 | $881.89K | 828,198 |
| Ari Bousbib See Remarks, Director | Oct 29, 2025 | Returned to company | −21,035 | $220.96 | $4.65M | 807,163 |
| Keriann Cherofsky See Remarks | Jul 28, 2025 | Tax withholding | −35 | $197.76 | $6.92K | 2,875 |
| Bhavik Patel See Remarks | Jul 28, 2025 | Tax withholding | −84 | $197.76 | $16.61K | 1,040 |
| Eric Sherbet See Remarks | Jul 23, 2025 | Returned to company | −6,070 | $190.10 | $1.15M | 21,108 |
| Eric Sherbet See Remarks | Jul 23, 2025 | Sale | −5,800 | $190.05 | $1.10M | 27,178 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| G. Berkshire James Officer | Sep 2, 2026 | 2,668 | $697.22K | Sep 2, 2026 | Stock Appreciation Rights |
| Staub Walter Officer | Aug 3, 2026 | 5,500 | $1.28M | Aug 3, 2026 | Restricted Stock |
| Patel Bhavik Officer | Jul 31, 2026 | 1,855 | $436.43K | Jul 31, 2026 | Performance Shares |
| Sherbet Eric Officer | Jul 29, 2026 | 5,000 | $1.25M | Jul 29, 2026 | Performance Shares |
| Bousbib Ari Officer, Director | Jul 29, 2026 | 106,279 | $26.09M | Jul 29, 2026 | Stock Appreciation Rights |
| Cherofsky Keriann Officer | Jul 29, 2026 | 558 | $136.83K | Jul 29, 2026 | Restricted Stock |
| Bousbib Ari Officer, Director | Dec 18, 2025 | 36,564 | $8.13M | Dec 18, 2025 | Stock Appreciation Rights |
| Sherbet Eric Officer | Oct 29, 2025 | 4,000 | $878.82K | Oct 29, 2025 | Stock Appreciation Rights |
| Bousbib Ari Officer, Director | Oct 29, 2025 | 56,557 | $12.46M | Oct 29, 2025 | Stock Appreciation Rights |
| Sherbet Eric Officer | Jul 23, 2025 | 5,800 | $1.10M | Jul 23, 2025 | Stock Appreciation Rights |
| Cherofsky Keriann Officer | Jul 23, 2025 | 549 | $105.15K | Jul 23, 2025 | Restricted Stock |
| Eric Sherbet Officer | Aug 27, 2024 | 1,300 | $320.23K | Aug 27, 2024 | PERFORMANCE SHARES |
| Ari Bousbib Officer | Mar 1, 2024 | 31,678 | $7.83M | Mar 1, 2024 | SARS |
| W. Richard Staub Officer | Feb 29, 2024 | 14,100 | $3.31M | Feb 29, 2024 | PERFORMANCE SHARES |
| Kevin C. Knightly Officer | Feb 28, 2024 | 8,607 | $2.05M | Feb 28, 2024 | SARS |